- $3.45bn
- $3.08bn
- $379.81m
Brief: CareDx Q1 revenue USD 77.3 million
Brief: Caredx Reports First Quarter 2023 Results
CareDx Inc reports results for the quarter ended in March - Earnings Summary
CareDx Inc expected to post a loss of 11 cents a share - Earnings Preview
CareDx Inc expected to post a loss of 11 cents a share - Earnings Preview
Brief: Caredx And Miromatrix Announce Exclusive Partnership To Advance Research Using Bioengineered Organs For Human Transplantation
Brief: Neil Gagnon Reports 6.2% Passive Stake In Caredx Inc As Of March 6 - SEC Filing
Brief: Caredx Inc Confirms Not Holding Cash Deposits Or Securities At Silicon Valley Bank
U.S. STOCKS ON THE MOVE-WeWork, Silvergate, Rivian, CrowdStrike
Stephens downgrades CareDx after new CMS policy
U.S. RESEARCH ROUNDUP-Tesla, Oracle, Caredx
U.S. RESEARCH ROUNDUP-Fubotv, Opal Fuels, Revolution Medicines
CareDx Inc reports results for the quarter ended in December - Earnings Summary
Brief: CareDx Reports Q4 Revenue Of $82.4 million
CareDx Inc expected to post a loss of 9 cents a share - Earnings Preview
CareDx Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Caredx Reports Preliminary Revenue Results For Q4 And Full Year 2022
CareDx up on $50 million stock repurchase program
Brief: CareDx Announces $50 Mln Stock Repurchase Program